|
| |
| | | 70221 | | 03.07.2026 | | Roche Pharma (Schweiz) AG | | | | | | | 09.02.2027 | | | | | | | | | | 07.16.10. | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Lunsumio subkutan 5 mg/0.5ml | Injektionslösung | Injection solution (Mosunetuzumabum 5mg / 0.5ml) | L01FX25 | | | 02 | Lunsumio subkutan 45 mg/1ml | Injektionslösung | Injection solution (Mosunetuzumabum 45 mg/ml) | L01FX25 | |
|
|
|
